12 Health Care Stocks Moving In Tuesday's After-Market Session
Portfolio Pulse from Benzinga Insights
12 health care stocks experienced significant movements in Tuesday's after-market session. Notable gainers include Autonomix Medical (AMIX), Unicycive Therapeutics (UNCY), and Venus Concept (VERO). Significant losers include Calidi Biotherapeutics (CLDI), BioSig Technologies (BSGM), and ThermoGenesis Holdings (THMO).
June 11, 2024 | 8:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
BioSig Technologies stock decreased by 14.88% to $0.4, with a market cap of $5.6 million.
The stock's significant decline suggests negative market sentiment, potentially leading to further short-term losses.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Calidi Biotherapeutics shares fell 15.3% to $0.23, with a market cap of $14.6 million.
The significant price drop indicates negative investor sentiment, likely leading to further short-term declines.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100
NEGATIVE IMPACT
ThermoGenesis Holdings shares decreased by 14.12% to $0.46, with a market cap of $3.6 million.
The significant price drop indicates negative investor sentiment, likely leading to further short-term declines.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
Autonomix Medical shares rose by 11.1% to $1.3, with a market cap of $24.4 million.
The significant price increase indicates positive investor sentiment, likely leading to further short-term gains.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Unicycive Therapeutics stock increased by 6.09% to $0.69, with a market cap of $26.1 million.
The stock's upward movement suggests positive market sentiment, potentially leading to short-term gains.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Venus Concept stock increased by 5.71% to $1.11, with a market cap of $7.0 million.
The stock's rise indicates positive investor sentiment, which may continue in the short term.
CONFIDENCE 80
IMPORTANCE 65
RELEVANCE 100